1) Fluid overload is associated with worse outcomes in patients with acute kidney injury (AKI), including increased mortality and decreased renal recovery. Several studies have shown relationships between greater fluid accumulation and higher risk of death.
2) Fluid balance may also impact renal recovery - more positive fluid balances are linked to less renal recovery in some studies. Restricting fluids appears beneficial for outcomes in some patients.
3) Choice of IV fluid may also influence AKI risk. Hydroxyethyl starches (HES) and liberal albumin administration are associated with higher rates of AKI compared to crystalloids in some studies. Chloride-restrictive IV solutions may reduce AKI compared to chloride-liberal fluids.
A neglected topic for way too long, the interest in fluid therapy seems to be quickly rising as the medical community is making a shift from looking at fluids as a mere method of stabilization towards the appreciation of its relevant side effects.
Many questions remain to be answered indeed:
Is the upgrade from saline 0.9% to balanced crystalloids worth the extra cost?
Does HES still have a place in the OR?
Do we have to fill the gap left by HES on ICU with crystalloids, other colloids or even albumin?
Is it really impossible to avoid fluid overload by using only crystalloids?
Is there still a definitive place for human albumin?
How do we treat and monitor specific patient populations, like patients with trauma, liver failure, brain edema and right heart failure among others?
How do we avoid a one-size-fits-all regimen in perioperative goal-directed therapy?
What with the fluids beyond resuscitation?
And what do the authors of the big fluid trials do in real life themselves?
The 9th International Fluid Academy Day will again be a 1 day concise meeting on all aspects of fluid managament and hemodynamic monitoring in the critically ill.
Date: October 26th 2019, 8:00 - 18:00
Advancing dialysis multinational guidelines for increased time and frequency ...AdvancingDialysis.org
Clinical practice guidelines and appropriate indications from 5 medical societies in North America, Europe and Asia for increased hemodialysis frequency and time.
Edelman-derived quantification of dyselectrolytemias.
Equation-based monitoring of hyponatremia therapy with a focus on safely and predictably increasing sodium as per guideline advice using a strategy involving desmopressin administration in severe hyponatremias, especially those patients at risk of becoming overcorrectors. Explanation of risk factors responsible for overshooting when correcting hyponatremia. Adrogue-Madias, Barsoum, Nguyen-Kurtz equations are explained and proven to be of help at least conceptually when attempting to have a desmopressin-guided therapy in hyponatremia. All recommendations are done in accordance with European and American guidelines published in 2013 and 2014.
A neglected topic for way too long, the interest in fluid therapy seems to be quickly rising as the medical community is making a shift from looking at fluids as a mere method of stabilization towards the appreciation of its relevant side effects.
Many questions remain to be answered indeed:
Is the upgrade from saline 0.9% to balanced crystalloids worth the extra cost?
Does HES still have a place in the OR?
Do we have to fill the gap left by HES on ICU with crystalloids, other colloids or even albumin?
Is it really impossible to avoid fluid overload by using only crystalloids?
Is there still a definitive place for human albumin?
How do we treat and monitor specific patient populations, like patients with trauma, liver failure, brain edema and right heart failure among others?
How do we avoid a one-size-fits-all regimen in perioperative goal-directed therapy?
What with the fluids beyond resuscitation?
And what do the authors of the big fluid trials do in real life themselves?
The 9th International Fluid Academy Day will again be a 1 day concise meeting on all aspects of fluid managament and hemodynamic monitoring in the critically ill.
Date: October 26th 2019, 8:00 - 18:00
Advancing dialysis multinational guidelines for increased time and frequency ...AdvancingDialysis.org
Clinical practice guidelines and appropriate indications from 5 medical societies in North America, Europe and Asia for increased hemodialysis frequency and time.
Edelman-derived quantification of dyselectrolytemias.
Equation-based monitoring of hyponatremia therapy with a focus on safely and predictably increasing sodium as per guideline advice using a strategy involving desmopressin administration in severe hyponatremias, especially those patients at risk of becoming overcorrectors. Explanation of risk factors responsible for overshooting when correcting hyponatremia. Adrogue-Madias, Barsoum, Nguyen-Kurtz equations are explained and proven to be of help at least conceptually when attempting to have a desmopressin-guided therapy in hyponatremia. All recommendations are done in accordance with European and American guidelines published in 2013 and 2014.
When to Initiate RRT in Patients with AKI - Does Timing Matter?Apollo Hospitals
Acute kidney injury is a serious illness which occurs commonly in the renal units and also in the ICU setting. It is an independent risk factor of increased mortality and morbidity, particularly when RRT is needed. The wide variation in utilization of RRT contributes to a lack of consensus among clinicians regarding the parameters which should guide the decision to initiate RRT. This problem is confounded by a paucity of high quality evidence in the current literature. This review examines the role of usual biochemical parameters as well as conventional clinical indications for commencing RRT. It also discusses the potential role of biomarkers as predictors for the need of RRT in AKI. Initiating dialysis in AKI should be based on dynamic clinical criteria and not only on specific biochemical values.
When to Initiate RRT in Patients with AKI - Does Timing Matter?Apollo Hospitals
Acute kidney injury is a serious illness which occurs commonly in the renal units and also in the ICU setting. It is an independent risk factor of increased mortality and morbidity, particularly when RRT is needed. The wide variation in utilization of RRT contributes to a lack of consensus among clinicians regarding the parameters which should guide the decision to initiate RRT.
Buying time in situations of extreme hemodynamic instability by partially reversing acidemia with a controlled strategy involving bicarbonate, calcium and hyperventilation.
Minimizing CO2 buildup as well as resulting hypocalcemia after alkalinization improves hemodynamics in a rat-derived french study.
- Recorded videos of the lecture:
English Language version of this lecture is available at: https://youtu.be/-Ynxvhbcl7U
Arabic Language version of this lecture is available at: https://youtu.be/QpK_toctVlw
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
A neglected topic for way too long, the interest in fluid therapy seems to be quickly rising as the medical community is making a shift from looking at fluids as a mere method of stabilization towards the appreciation of its relevant side effects.
Many questions remain to be answered indeed:
Is the upgrade from saline 0.9% to balanced crystalloids worth the extra cost?
Does HES still have a place in the OR?
Do we have to fill the gap left by HES on ICU with crystalloids, other colloids or even albumin?
Is it really impossible to avoid fluid overload by using only crystalloids?
Is there still a definitive place for human albumin?
How do we treat and monitor specific patient populations, like patients with trauma, liver failure, brain edema and right heart failure among others?
How do we avoid a one-size-fits-all regimen in perioperative goal-directed therapy?
What with the fluids beyond resuscitation?
And what do the authors of the big fluid trials do in real life themselves?
The 9th International Fluid Academy Day will again be a 1 day concise meeting on all aspects of fluid managament and hemodynamic monitoring in the critically ill.
Date: October 26th 2019, 8:00 - 18:00
When to dialyse a patient and with what modality of dialysis will be topic of discussion.The recent advances and debates surrounding the topic will be discussed in detail
A neglected topic for way too long, the interest in fluid therapy seems to be quickly rising as the medical community is making a shift from looking at fluids as a mere method of stabilization towards the appreciation of its relevant side effects.
Many questions remain to be answered indeed:
Is the upgrade from saline 0.9% to balanced crystalloids worth the extra cost?
Does HES still have a place in the OR?
Do we have to fill the gap left by HES on ICU with crystalloids, other colloids or even albumin?
Is it really impossible to avoid fluid overload by using only crystalloids?
Is there still a definitive place for human albumin?
How do we treat and monitor specific patient populations, like patients with trauma, liver failure, brain edema and right heart failure among others?
How do we avoid a one-size-fits-all regimen in perioperative goal-directed therapy?
What with the fluids beyond resuscitation?
And what do the authors of the big fluid trials do in real life themselves?
The 9th International Fluid Academy Day will again be a 1 day concise meeting on all aspects of fluid managament and hemodynamic monitoring in the critically ill.
Date: October 26th 2019, 8:00 - 18:00
A neglected topic for way too long, the interest in fluid therapy seems to be quickly rising as the medical community is making a shift from looking at fluids as a mere method of stabilization towards the appreciation of its relevant side effects.
Many questions remain to be answered indeed:
Is the upgrade from saline 0.9% to balanced crystalloids worth the extra cost?
Does HES still have a place in the OR?
Do we have to fill the gap left by HES on ICU with crystalloids, other colloids or even albumin?
Is it really impossible to avoid fluid overload by using only crystalloids?
Is there still a definitive place for human albumin?
How do we treat and monitor specific patient populations, like patients with trauma, liver failure, brain edema and right heart failure among others?
How do we avoid a one-size-fits-all regimen in perioperative goal-directed therapy?
What with the fluids beyond resuscitation?
And what do the authors of the big fluid trials do in real life themselves?
The 9th International Fluid Academy Day will again be a 1 day concise meeting on all aspects of fluid managament and hemodynamic monitoring in the critically ill.
Date: October 26th 2019, 8:00 - 18:00
A talk by Max Bell at the 2017 meeting of the Scandinavian Society of Anaestesiology and Intensive Care Medicine.
All available content from SSAI2017: https://scanfoam.org/ssai2017/
Delivered in collaboration between scanFOAM, SSAI & SFAI.
When to Initiate RRT in Patients with AKI - Does Timing Matter?Apollo Hospitals
Acute kidney injury is a serious illness which occurs commonly in the renal units and also in the ICU setting. It is an independent risk factor of increased mortality and morbidity, particularly when RRT is needed. The wide variation in utilization of RRT contributes to a lack of consensus among clinicians regarding the parameters which should guide the decision to initiate RRT. This problem is confounded by a paucity of high quality evidence in the current literature. This review examines the role of usual biochemical parameters as well as conventional clinical indications for commencing RRT. It also discusses the potential role of biomarkers as predictors for the need of RRT in AKI. Initiating dialysis in AKI should be based on dynamic clinical criteria and not only on specific biochemical values.
When to Initiate RRT in Patients with AKI - Does Timing Matter?Apollo Hospitals
Acute kidney injury is a serious illness which occurs commonly in the renal units and also in the ICU setting. It is an independent risk factor of increased mortality and morbidity, particularly when RRT is needed. The wide variation in utilization of RRT contributes to a lack of consensus among clinicians regarding the parameters which should guide the decision to initiate RRT.
Buying time in situations of extreme hemodynamic instability by partially reversing acidemia with a controlled strategy involving bicarbonate, calcium and hyperventilation.
Minimizing CO2 buildup as well as resulting hypocalcemia after alkalinization improves hemodynamics in a rat-derived french study.
- Recorded videos of the lecture:
English Language version of this lecture is available at: https://youtu.be/-Ynxvhbcl7U
Arabic Language version of this lecture is available at: https://youtu.be/QpK_toctVlw
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
A neglected topic for way too long, the interest in fluid therapy seems to be quickly rising as the medical community is making a shift from looking at fluids as a mere method of stabilization towards the appreciation of its relevant side effects.
Many questions remain to be answered indeed:
Is the upgrade from saline 0.9% to balanced crystalloids worth the extra cost?
Does HES still have a place in the OR?
Do we have to fill the gap left by HES on ICU with crystalloids, other colloids or even albumin?
Is it really impossible to avoid fluid overload by using only crystalloids?
Is there still a definitive place for human albumin?
How do we treat and monitor specific patient populations, like patients with trauma, liver failure, brain edema and right heart failure among others?
How do we avoid a one-size-fits-all regimen in perioperative goal-directed therapy?
What with the fluids beyond resuscitation?
And what do the authors of the big fluid trials do in real life themselves?
The 9th International Fluid Academy Day will again be a 1 day concise meeting on all aspects of fluid managament and hemodynamic monitoring in the critically ill.
Date: October 26th 2019, 8:00 - 18:00
When to dialyse a patient and with what modality of dialysis will be topic of discussion.The recent advances and debates surrounding the topic will be discussed in detail
A neglected topic for way too long, the interest in fluid therapy seems to be quickly rising as the medical community is making a shift from looking at fluids as a mere method of stabilization towards the appreciation of its relevant side effects.
Many questions remain to be answered indeed:
Is the upgrade from saline 0.9% to balanced crystalloids worth the extra cost?
Does HES still have a place in the OR?
Do we have to fill the gap left by HES on ICU with crystalloids, other colloids or even albumin?
Is it really impossible to avoid fluid overload by using only crystalloids?
Is there still a definitive place for human albumin?
How do we treat and monitor specific patient populations, like patients with trauma, liver failure, brain edema and right heart failure among others?
How do we avoid a one-size-fits-all regimen in perioperative goal-directed therapy?
What with the fluids beyond resuscitation?
And what do the authors of the big fluid trials do in real life themselves?
The 9th International Fluid Academy Day will again be a 1 day concise meeting on all aspects of fluid managament and hemodynamic monitoring in the critically ill.
Date: October 26th 2019, 8:00 - 18:00
A neglected topic for way too long, the interest in fluid therapy seems to be quickly rising as the medical community is making a shift from looking at fluids as a mere method of stabilization towards the appreciation of its relevant side effects.
Many questions remain to be answered indeed:
Is the upgrade from saline 0.9% to balanced crystalloids worth the extra cost?
Does HES still have a place in the OR?
Do we have to fill the gap left by HES on ICU with crystalloids, other colloids or even albumin?
Is it really impossible to avoid fluid overload by using only crystalloids?
Is there still a definitive place for human albumin?
How do we treat and monitor specific patient populations, like patients with trauma, liver failure, brain edema and right heart failure among others?
How do we avoid a one-size-fits-all regimen in perioperative goal-directed therapy?
What with the fluids beyond resuscitation?
And what do the authors of the big fluid trials do in real life themselves?
The 9th International Fluid Academy Day will again be a 1 day concise meeting on all aspects of fluid managament and hemodynamic monitoring in the critically ill.
Date: October 26th 2019, 8:00 - 18:00
A talk by Max Bell at the 2017 meeting of the Scandinavian Society of Anaestesiology and Intensive Care Medicine.
All available content from SSAI2017: https://scanfoam.org/ssai2017/
Delivered in collaboration between scanFOAM, SSAI & SFAI.
ICN VIctoria: John Botha on Critical Care Renal FailureGerard Fennessy
Professor John Botha from Frankston Hospital in Melbourne talks at the April 2014 Victorian Intensive Care Network meeting on Renal Failure in Critical Care
Association between the choice of IV crystalloid and in-hMargaritoWhitt221
Association between the choice of IV crystalloid and in-hospital mortality
among critically ill adults with sepsis
Raghunathan K, Shaw A, Nathanson B, et al.
Critical Care Medicine, July 2014
INTRODUCTION
Background
• Fluid therapy is used to restore effective circulating blood volume and to promote tissue/organ perfusion.
• Guidelines recommend early resuscitation with IV crystalloids as the preferred fluid therapy and against
using hydroxyethyl starches due to increased risk of AKI.
• Resuscitation with isotonic saline can induce hyperchloremia and metabolic acidosis and have been
associated with alterations in renal blood flood and effects on immune function.
• Balanced fluids avoid biochemical effects and have been associated with reduced perioperative mortality
and ICU morbidity.
Current
Thoughts
• Crystalloids differ in chloride content and strong ion difference (SID = sodium - chloride conc):
- Lactated Ringer’s solution (LR): contains electrolytes, a high SID and physiologic chloride content
- Isotonic saline (IS): does not contain electrolytes, has an SID = 0 and supraphysiologic chloride content
STUDY OVERVIEW
Study Type • Retrospective cohort study
Objective • To examine the association between receipt of balanced fluids vs. nonbalanced fluids during initial
resuscitation and in-hospital mortality, renal morbidity, ICU and hospital lengths of stay in a large cohort of
adults admitted with vasopressor-dependent sepsis
Enrollment • 53,448 critically ill adult patients who were admitted to one of at least 360 geographically and structurally
diverse hospitals in the US between November 2005 and December 2010
• 6,730 patients studied (3,365 patients in each group)
Inclusion
Criteria
• Critically ill patients ≥18 years old
• Primary or secondary diagnosis of sepsis
• Receiving vasopressors and received at least 2L of crystalloids for resuscitation by day 2
• Blood cultures and 3 consecutive days of antibiotic treatment
Exclusion
Criteria
• Early adverse outcomes (e.g. ARF) that could dictate fluid choice
• ESRD on dialysis PTA
• Surgery
• Transferred out of the ICU
Outcomes • Primary outcome: in-hospital mortality after hospital day 2
• Secondary outcomes: ARF ± dialysis, hospital and ICU lengths of stay
STUDY DESIGN & METHODS
Study
Design
• Dose-response relationships were analyzed according to the proportion of balanced fluids received
• Controlled for differences severity of illness and patient management (e.g. monitoring procedures,
utilization of diagnostic tests, administration of supportive therapies and pharmacologic treatments)
• Adjusted for confounding influence of hospital-specific factors (practice variation)
• Conducted secondary sensitivity analyses
Statistical
Analysis
• All analyses were performed using Stat/SE 11.2
• Cohorts assembled by application of inclusion/exclusion criteria and evaluated for balance on all measured
covariate ...
A talk by Sara Crager at TBS24
Shock isn’t about hypotension, it’s about hypoperfusion. While we know this in theory, we don’t do a great job of applying it in practice. In order to move beyond our reliance on blood pressure to recognize shock at the bedside, we need to stop thinking about shock as a diagnosis and instead think about it as a continuum.
Fully Automated CPR | Jason van der Velde | TBS24scanFOAM
Embark on a fascinating exploration of Fully Automated Cardiac Arrest Management with Dr. Jason van der Velde, who’s been part of a team refining the FA-CPR algorithm since 2019. Gain unique insights into real-world applications and ongoing research opportunities in optimising the “Low Flow State” through innovative approaches like Chest Compression Synchronised Ventilation (CCSV). Dr. Van der Velde shares an iterative journey, supported by real-life data, underscoring the profound impact of personalised CPR tailored to individual patients in rural Ireland. The talk goes beyond conventional guidelines, delving into the intricate science and human factors essential for achieving substantial improvements in Return of Spontaneous Circulation (ROSC) rates. Attendees will leave with a deep understanding of the potential of Fully Automated CPR with CCSV as a dynamic and continually evolving strategy, acting as a strategic placeholder to buy essential time for comprehensive diagnostics and personalised interventions. The presentation hints at transformative possibilities in resuscitation science, featuring case studies that showcase the concept of bridging patients to definitive interventions such as cardiac angiography and Extracorporeal Membrane Oxygenation (ECMO).
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
This document is designed as an introductory to medical students,nursing students,midwives or other healthcare trainees to improve their understanding about how health system in Sri Lanka cares children health.
Cold Sores: Causes, Treatments, and Prevention Strategies | The Lifesciences ...The Lifesciences Magazine
Cold Sores, medically known as herpes labialis, are caused by the herpes simplex virus (HSV). HSV-1 is primarily responsible for cold sores, although HSV-2 can also contribute in some cases.
KEY Points of Leicester travel clinic In London doc.docxNX Healthcare
In order to protect visitors' safety and wellbeing, Travel Clinic Leicester offers a wide range of travel-related health treatments, including individualized counseling and vaccines. Our team of medical experts specializes in getting people ready for international travel, with a particular emphasis on vaccines and health consultations to prevent travel-related illnesses. We provide a range of travel-related services, such as health concerns unique to a trip, prevention of malaria, and travel-related medical supplies. Our clinic is dedicated to providing top-notch care, keeping abreast of the most recent recommendations for vaccinations and travel health precautions. The goal of Travel Clinic Leicester is to keep you safe and well-rested no matter what kind of travel you choose—business, pleasure, or adventure.
TOP AND BEST GLUTE BUILDER A 606 | Fitking FitnessFitking Fitness
"Feature:
• Intelligent Ergonomically Design Glute Builder Is A Must Have For Those Looking To Target Their Gluteal Muscles And Hamstrings With Precision.
• The Ability To Adjust The Starting Position, This Machine Allows For A More Targeted Workout That Is Tailored To Your Specific Needs.
• Spacious And Supportive Cushioned Seat Provide Added Comfort And Stability During Your Workout."
Get more information visit on:- www.fitking.in
Our mail I.D:-care@fitking.in, fitking.in@gmail.com
Call us at :- 9958880790, 9870336406, 8800695917
1. Fluids in the PACU, the easy way out?
Max Bell
MD, PhD
Karolinska University Hospital/Karolinska Institutet
2. Importance
Acute kidney injury (AKI) is common after surgery
It is associated with increased mortality and long-term renal
dysfunction
Perhaps there is room for improvement, preoperatively,
intraoperatively and in the postoperative period
4. How dangerous?
•“At 10-year follow-up, adjusted cardiovascular-specific mortality
estimates were 6%, 11%, 12%, 19%, and 27% for patients with no
kidney disease, AKI with no CKD, CKD with no AKI, AKI with CKD, and
ESRD, respectively (P < 0.001).”
•Registry study (single center) of >50 000 patients
Ann Surg. 2016 Dec;264(6):987-996.
•”In eight studies that reported the short-term mortality, relative risk of
death in the presence of post-operative AKI was 12.6 fold (95% CI,
6.8-23.4).”
•Systematic review (in total n=82,514; 19 studies)
Intensive care medicine. 2016;42(4):521-30.
5. Pathophysiology (major surgery->AKI), simplified
•Major surgery involves large shifts in volume
•Hypotension is common (and perhaps underappreciated*)
•Blood loss
•Intraperitoneal insults can compromise renal blood flow
•Inflammation-surgical trauma
•Other adverse events like massive blood loss-transfusion, severe
hypotension, bacterial leakage, hypoxia etc
6. Pathophysiology (major surgery->AKI), simplified (2)
•Use of harmful substances for the kidney such as contrast media,
nephrotoxic antibiotics, and NSAIDs
•Preop:
•Advanced age
•Comorbidities (common+predispose to a greater risk of AKI)
•Diabetes
•Chronic kidney disease (CKD)
•Heart failure
•Demographic shifts: complex surgery is now performed in older and
more chronically ill patients, increasing the number of patients at risk
9. Prevention of postoperative AKI [preop]
•Identify patients at risk
•Advanced age
•CKD
•Multiple comorbidities
•Surgery during critical illness
•Surgery with an ongoing infection
•Planned surgery will compromise renal blood flow?
•Act
•Surgical approach in high risk patients (no data but endovascular
aortic repair>open AAA surgery with renal flow occlusion?)
•Correct anemia
10. Prevention of postoperative AKI [intraop]
•Identify patients at risk
•Advanced age
•CKD
•Multiple comorbidities
•Surgery during critical illness
•Surgery with an ongoing infection
•Planned surgery will compromise renal blood flow?
•Act
•Extreme vigilance with regards to hypotension – use patients own
baseline*
•Avoid hypovolemia
•Adequate (so, so easy to write) cardiac output
•Avoid (if possible) starch, contrast, aminoglycosides, NSAIDs
•Beware of hypervolemia!
•Transfusions when necessary
•Intraoperative oliguria – not always a trigger for volume!
•Diuretics in hypervolemia *if* positive response
11. *Hypotension and AKI
• Univariate analysis
– Sex
– Comorbity
– BP medication
– Preop creatinine
– Intraop hypotension
– Postop fluid balance
EJA 2017, In Press
12. *Hypotension and AKI
Risk factor OR
(unadjusted)
(95% CI)
OR (adjusteda)
(95% CI)
OR (adjustedb)
(95% CI)
Hypotensive event*
(>40-≤50%) vs ≤40%
1.56 (0.98-
2.48)
1.61 (0.99-2.62) 1.48 (0.90-2.44)
Hypotensive event*
(>50%) vs ≤ 40%
2.38 (1.30-
4.36)
2.27 (1.20-4.30) 2.02 (1.05-3.89)
EJA 2017, In Press
*Decrease in systolic blood pressure in percent relative to baseline for >5 min.
aAdjusted for the covariates: gender (male), ASA>2, treated hypertension,
pre-operative creatinine >90µmol/L and fluid balance in quartiles.
b Adjusted for the covariates mentioned above and blood loss in quartiles.
•Multivariable analysis
13. Goal directed prevention of postoperative AKI [intraop]
•The OPTIMISE trial (major GI surgery) found a cardiac output-guided
fluid and vasopressor treatment algorithm to lead to fewer
postoperative complications (such as ischemic insults, respiratory
failure, and AKI), but no postop mortality reduction
JAMA 2014; 311: 2181–2190
•RCT of transpulmonary thermodilution to guide goal-directed therapy
neither found the intervention to increase the rate of achieved
hemodynamic targets (!) nor (unsurprisingly) to reduce the
postoperative increase in creatinine
•But same study - intraoperative hypotension and hypovolemia:
the most important risk factors for postoperative AKI
Crit Care 2016; 20:50
14. Fluids peri- and postoperatively
•OPTIMISE: total amount of iv fluids did not differ between the
treatment arms, ~4000 ml, but the intervention group received more
colloids of any type….even starch…
•Ok, so avoid starch (6S, CHEST etc)
•Balanced solutions>0.9% sodium chloride? (SPLIT trial, but more
data needed)
•RELIEF: restrictive vs liberal fluid therapy in major abdominal surgery
•Randomized 3000 patients and one endpoint is AKI assessed by
creatinine [to be published in 2018]
•Peri/postoperative oliguria – a trigger for fluids? Sometimes yes, more
often nope, nein, nichts, nihil, nej.
Goren O, Matot I. Perioperative acute kidney injury. Br J Anaesth 2015;
115(Suppl 2):ii3–ii14
15. More on fluids in the PACU
•A meta-analysis including RCTs comparing goal-directed therapy with
standard therapy in mixed patient populations found GDT to prevent
AKI – but….
•Wide periods of time – large shifts in how we use fluids, both with
regards to overall volume and type of fluid
Anesth Analg 2016; 122:173–185.
•The use of “maintenance fluids” in AUS/NZ has decreased
significantly from 2011-14
Crit Care Resusc 2016; 18:89–94
•Use of starch for obv reasons in decline; 67% reduction in AUS/NZ
and 82% in Denmark
Acta Anaesthesiol Scand 2017; 61:532–538.
Crit Care Resusc 2017; 19:134–141.
16. Fluids in the PACU: conclusions
•Varying definitions for AKI have distorted comparability of studies
•Around one-fifth of patients undergoing major noncardiac surgery
develop an increase in creatinine or oliguria or both
•AKI increases risk for postop adverse outcomes including death
•Recognizing high-risk patients preoperatively: important!
•Prompt treatment of intraoperative hypotension and
hypoperfusion
•Avoiding nephrotoxins
•The large multicenter RCT of restrictive vs liberal fluid
management in major abdominal surgery (RELIEF) will aid in how
to optimize perioperative fluid management
19. American Journal of Kidney Diseases
Volume 55, Issue 2, February 2010, Pages 316–3
20. American Journal of Kidney Diseases
Volume 55, Issue 2, February 2010, Pages 316–325
21. Fluid accumulation and 60-day mortality
data from the SOAP study
Payen et al, Critical Care 2008
22. Fluid overload and 60-day mortality
a PICARD study
Bouchard et al, Kidney Int 2009
Adjusted
OR*
95% CI
FO at dialysis initiation 2.07 1.27–3.37
FO at dialysis cessation 2.52 1.55–4.08
FO at AKI diagnosis (non-dialyzed patients) 3.14 1.18–8.33
*Adjusted for illness severity (APACHE III score) and initial dialysis modality
Adjusted OR for death associated with fluid overload (FO)
FO: Fluid-related weight gain of >10% over baseline
(Total fluid intake – Total output) × 100 / body weight
23. Fluid balance and 60-day mortality in AKI patients with ALI
data from the FACTT
Grams et al, Clin J Am Soc Nephrol 2012
24. Fluid balance and 60-day mortality in AKI patients with ALI
data from the FACTT
Grams et al, Clin J Am Soc Nephrol 2012
Adjusted
OR*
95% CI P
Fluid Balance post-AKI (mean L/day) 1.61 1.32-1.96 <0.001
* Adjusting for age, sex, race, fluid-strategy randomization group, catheter randomization group,
day first diagnosed with AKI, APACHE III score, mean daily CVP, presence of shock
25. Fluid balance and 28-day mortality in AKI patients
data from the NEFROINT study
Teixeira et al, Critical Care 2013
26. Fluid balance and 28-day mortality in AKI patients
data from the NEFROINT study
Teixeira et al, Critical Care 2013
Adjusted
HR*
95% CI P
Mean Fluid Balance (L/day) 1.67 1.33-2.09 <0.001
Mean Urine Volume (L/day) 0.47 0.33-0.67 <0.001
Diuretic use 0.25 0.12-0.52 <0.001
Diabetes 2.16 1.09-4.26 0.027
Hypertension 2.18 1.12-4.22 0.021
* Variables considered in the model: age, gender, diabetes, hypertension, cardiovascular disease,
non-renal SOFA, sepsis, mean fluid balance, mean urine volume and diuretic use
Table 3. Cox regression analysis for 28-day mortality
27. Fluid overload at RRT initiation and 90-day mortality
data from the FINNAKI study
Vaara et al, Critical Care 2012
28. Fluid overload at RRT initiation and 1-year mortality
Heung et al, Nephrol Dial Transplant 2012
34. Fluid balance and renal recovery
Reference Study type Population
(n)
Mean fluid balance
in restrictive
group
Mean fluid balance
in liberal group
Renal outcome with
more restrictive
strategy
FACTT, 2006 RCT ALI
(1,000)
-136 ml on day 7 +6,992 ml on day 7 Trend toward less RRT
(p = 0.06)
Bouchard, 2009 Retrospective Mixed ICU+AKI
(542)
<10% rise at AKI
diagnosis or RRT
initiation
>10% rise at AKI
diagnosis or RRT
initiation
No difference
Bouchard, 2009 Retrospective Mixed ICU+AKI
(542)
<10% rise at peak
creatinine
>10% rise at peak
creatinine
Increased renal
recovery (p = 0.007,
adjusted for APACHE
III score)
Grams, 2011
(FACTT)
Retrospective ALI and AKI
(306)
+3,700 ml on day 7 +10,200 ml on day 7 No difference in RRT
requirement
Heung, 2012 Retrospective RRT
(170)
<10% fluid overload
at RRT initiation
>10% fluid overload
at RRT initiation
Increased likelihood of
RRT discontinuation
within 1 year (p = 0.02)
RENAL, 2012 Retrospective RRT
(1,453)
Negative mean daily
FB
Positive mean daily
FB
Increased RRT-free
days (p = 0.0017)
38. Fluids
HES vs. crystalloids
Reference Study type Patients
(n)
Fluids Outcome with HES
VISEP trial, 2008 RCT Severe sepsis
(537)
10% HES 200/0.5
vs.
Ringer’s lactate
More AKI (p = 0.002)
More RRT (p = 0.001)
Schortgen, 2008 Prospective
cohort study
Shock
(822)
Increased risk for AKI with
artificial hyperoncotic colloids
(OR 2.13)
Rioux, 2009 Retrospective Cardiac surgery
(563)
HES 200/0.5 vs. Pentastarch associated with
an increased risk of AKI (OR
1.08 per ml/kg)
Perner, 2012 (6S) RCT Severe sepsis
(804)
6% HES 130/0.4
vs.
Ringer-Acetate
Myburgh, 2012
(CHEST)
RCT ICU
(7000)
6% HES 130/0.4
vs.
0.9% Saline
More patients needed RRT
(RR 1.21 [1.00-1.45]). No
difference in 90-day mortality
39. Fluids
Albumin vs. Crystalloids
Reference Study type Patients
(n)
Fluids Outcome with Albumin
Schortgen, 2008 Prospective
cohort study
Shock
(232)
20-25% Albumin
vs.
Crystalloids
Increased risk for AKI (OR 5.27
[2.44-11.37]) and ICU mortality
(OR 2.76 [1.41-5.41])
SAFE study, 2004 RCT ICU
(7000)
4% Albumin
vs.
0.9% saline
No difference in duration of
RRT or 28-day mortality
SAFE substudy
on TBI, 2007
Post hoc TBI
(406)
4% Albumin
vs.
0.9% saline
Higher 2-year mortaity (OR
1.63 [1.17-2.26])
SAFE substudy
on severe sepsis,
2011
Post hoc Severe sepsis
(1218)
4% Albumin
vs.
0.9% saline
Lower 2-year mortality (OR 0.7
[0.52-0.97])
No difference in renal SOFA or
RRT requirement
40. Fluids
Chloride liberal vs. Chloride restrictive
Reference Study type Patients
(n)
Fluids Outcome with Chloride-
restrictive strategy
Yunos, 2012 Prospective
cohort study
ICU
(1533)
Liberal administration of
chloride-rich solutions
vs.
Chloride restrictive
strategy
Decreased risk for AKI (OR
0.52 [0.37-0.75]) and use of
RRT (OR 0.52[0.33-0.81])
Shaw, 2012 Retrospective
cohort study
Surgery
(3704)
0.9% Saline
vs.
Plasma-Lyte®
Less need for acute dialysis (p
<0.001)
41. Over-zealous fluid resuscitation may lead to fluid overload.
Can fluid overload worsen AKI?
• Link between FO, abdominal compartment syndrome and
AKI (Dalfino, 2008 707-713)
• Elevated CVP strong predictor of progression of renal
failure in CHF patients (Mullens, 2009 598-596)
• AKI is associated with elevated renal interstitial pressure
(reflecting renal edema) (Herrler, 2010 40-46)
Summary
43. Prompt and targeted correction of volume deficit – may reduce later
volume requirements. Stop when preload is sufficient to generate
adequate CO – may require earlier or greater use ov vasopressors
Recommendations
Editor's Notes
Use of fluids and fluid overload: extremely difficult to draw conclusions from non-randomized trials
A large retrospective analysis in 2557 patient from our center that underwent right heart catheterization showed
that central venous pressure (CVP) is associated with estimated GFR (eGFR) in a bimodal fashion, with the
highest eGFR at a CVP of approximately 3 mmHg and a progressively lower eGFR in subjects with CVP above
5–6 mm Hg, comprising approximately one-third of the population. Remarkably, is shown in Fig. 1 , this bimodal
association was independent of cardiac index (the analysis was adjusted for age, sex and cardiac index)
The right figure shows the association between CVP and GFR according to different cardiac index values
A six-hour initial resuscitation bundle, including aggressive fluid administration was associated with better prognosis (Rivers, 2001). In that trial, fluid administration was greater in the
treatment group from 0 to 6 h, but, importantly, overall fluid administration was not significantly different between groups over the first 72 h
These data suggest that prompt, targeted resuscitation can spare later fluid requirements.
Vätskeöverskott vid CRRT-start hos kritiskt sjuka barn – data från the prospective pediatric CRRT registry (ppCRRT).
%VÄTSKEÖVERSKOTT= Vätska in-vätska ut/IVA-in-vikt *100%.
American Journal of Kidney Diseases
Volume 55, Issue 2, February 2010, Pages 316–325
Original Investigation
Fluid Overload and Mortality in Children Receiving Continuous Renal Replacement Therapy: The Prospective Pediatric Continuous Renal Replacement Therapy Registry
Scott M. Sutherland, MD1, , ,
Michael Zappitelli, MD, MSc2,
Steven R. Alexander, MD1,
Annabelle N. Chua, MD3,
Patrick D. Brophy, MD4,
Timothy E. Bunchman, MD5,
Richard Hackbarth, MD5,
Michael J.G. Somers, MD6,
Michelle Baum, MD6,
Jordan M. Symons, MD7,
Francisco X. Flores, MD8,
Mark Benfield,MD9,
David Askenazi, MD9,
Deepa Chand, MD10,
James D. Fortenberry, MD11,
John D. Mahan, MD12,
Kevin McBryde, MD13,
Douglas Blowey, MD14,
Stuart L. Goldstein, MD3
1120 pts with ARF from SOAP. In addition, multivariate regression analysis demonstrated that mean daily fluid was a significant and independent mortality predictor. Specifically, a 1 L positive fluid balance per 24 hrs was associated with an approximate 20% increase in mortality risk.
This trial was an observational study in which fluid status was estimated quantitatively in 610 AKI patients. Of these patients, approximately two-thirds (396) required some form of dialysis. Fluid balance was estimated by measuring the sum of all fluid inputs (e.g., intravenous fluids, medications, nutrition, etc) and the sum of all fluid outputs (e.g., urine, stool, nasogastric fluid, etc). On a daily basis, “fluid accumulation” was calculated as the difference in these sums divided by the body weight at the time of hospital admission. These measurements were made starting three days before nephrology consultation and continued until hospital discharge. The study defined “fluid overload” as a fluid accumulation value of greater than 10% (i.e., the point at which a patient sustained a fluid-related weight gain of 10% from baseline).
As shown in the table, the patients who met the 10% fluid overload criterion at the time of AKI diagnosis were more critically ill than patients with lesser degrees of fluid accumulation. The fluid overload group had significantly higher APACHE III and SOFA scores, higher number of organ failures, and higher percentage of patients with respiratory failure, ventilator dependence, and sepsis or septic shock. It should be noted that the outcomes reported below are adjusted for the greater illness severity in the fluid overload group.
From the 1000 participants in FACTT, Grams and coworkers identified 306 patients meeting AKIN criteria for stage 1 AKI in the first 2 study days. These patients were included in this post-hoc analysis of the relationship between fluid balance and mortality. Fluid balance was calculated as the mean daily difference between fluid intake and fluid output from the development of AKI until day 7, death or withdrawal from study.
Fluid balance was calculated as the mean daily difference between fluid intake and fluid output from the development of AKI until day 7, death or withdrawal from study. In a multiple logistic regression model adjusting for multiple co-variates, they found a 61% increase in the risk of death for every 1 L increase in mean fluid balance per day. This association was consistent through multiple sensitivity analyses and across gender, fluid strategy, early and late oliguria and severity of AKI.
This secondary analysis of data from a multicenter, prospective cohort study in 10 Italian ICUs examined the influence of fluid balance and urine volume on 28-day mortality among critically ill patients with AKI. 132 patients with AKI (defined by renal SOFA score). This Figure demonstrates the pattern of cumulative fluid balance among survivors and non-survivors in the first 7 days in the ICU. Non-survivors consistently had higher mean cumulative fluid balance throughout the ICU stay and the magnitude of the difference between the groups increased with each additional day.
The cox regression analysis showed that mean fluid balance was independently associated with mortality. In this analysis, for every 1 L increase in mean fluid balance per day, a 67% increase in the risk of death was observed.
Retrospective analysis of 170 hospitalized adult patients with AKI who required RRT. Appprox. 60% received CRRT as initial modality. Most patients (80%) were treated in the ICU. %FO = (weight at RRT initiation – baseline weight) x 100/Baseline weight
They found no difference in mortality. The RENAL trial tested high vs. low intensity CRRT in 1500 ICU patients, and found no difference in 90 day mortality.
The same authors recently performed a post-hoc crunch of the data from the original RCT. They created separate survival plots for patients with or without a positive mean daily fluid balance during the first two study days (left fig) and from day 2 and onwards. Both analyses showed increased mortality in patients with early or late positive fluid balance.
A negative mean daily fluid balance was associated with a nearly 70% reduction in 90-day risk of death. Negative fluid balance was also independently associated with increased RRT-free days and fewer ICU and hospital days (p < 0.01).
In dialyzed patients, mortality increased in relation to the proportion of dialysis days with fluid overload. In the ICU, use of CRRT allows slow progressive fluid removal compared to the use of intermittent hemodialysis which has been associated with progressive fluid overload
Isolated rat kidneys were perfused with a constant pressure and stepwise incrememnts in renal vein pressure were investigated. GFR and sodium excretion fell progressively with increasing venous pressure. The underlying mechanism is still unknown but interstitial edema, increased distal tubular pressure as well as effects on renal blood flow and humoral factors mays play a role,
A large retrospective analysis in 2557 patient from our center that underwent right heart catheterization showed
that central venous pressure (CVP) is associated with estimated GFR (eGFR) in a bimodal fashion, with the
highest eGFR at a CVP of approximately 3 mmHg and a progressively lower eGFR in subjects with CVP above
5–6 mm Hg, comprising approximately one-third of the population. Remarkably, is shown in Fig. 1 , this bimodal
association was independent of cardiac index (the analysis was adjusted for age, sex and cardiac index)
The right figure shows the association between CVP and GFR according to different cardiac index values
Fluid balance is not reported in these studies.
Schotgen an colleagues compared the effect of hyperoncotic albumin vs. crystalloids on kidney function and ICU mortality in patients with shock. Resuscitation with hyperoncotic albumin was associated with an increased risk of AKI and mortality. The SAFE study randomized 7000 ICU patients to either 4% Albumin or normal saline for fluid resuscitation and found no differences in 28-day mortality or renal outcomes.